Laboratori Baldacci S.P.A.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Apr 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 29, 2027The maintenance fee for Pyrrolidone carboxylic acid (PCA) for ophthalmic use (US 10,456,374) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
- 1 fee due Jul 9, 2027The maintenance fee for Product Based on Iron Bis-Glycinate Chelate and Alginic Acid And/Or Water-Soluble Salts Thereof, Formulations Thereof, and Pharmaceutical Uses Thereof (US 11,865,099) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,202,903 | Use of aminaphtone for the preparation of a medicament for treating arteriopathies In force · From the USPTO record | In force | From the USPTO record | |
| US 10,028,929 | Method of treating raynaud's disease secondary to connectivitis using aminaphtone In force · From the USPTO record | In force | From the USPTO record | |
| US 8,987,503 | Process for the Synthesis of Aminaphtone In force · High confidence | In force | High confidence | |
| US 10,456,374 | Pyrrolidone carboxylic acid (PCA) for ophthalmic use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,272,067 | Pyrrolidone Carboxylic Acid (PCA) for Ophthalmic Use In force · High confidence | In force | High confidence | |
| US 11,213,505 | Product Based on Iron Bis-Glycinate Chelate and Alginic Acid And/Or Water-Soluble Salts Thereof, Formulations Thereof, and Pharmaceutical Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,865,099 | Product Based on Iron Bis-Glycinate Chelate and Alginic Acid And/Or Water-Soluble Salts Thereof, Formulations Thereof, and Pharmaceutical Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,546,756 | Mixture of Isomers of Aminaphtone, Analytical Method for Identifying Them and Pharmaceutical Composition Comprising Said Isomers In force · High confidence | In force | High confidence |
Also on record, not counted in the 8: 1 lapsed for an unpaid fee · 8 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 2 no status recorded